<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2020/05/cvs-free-delivery-coronavirus-1584020000-740x416.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2020/05/cvs-free-delivery-coronavirus-1584020000-740x416.jpg"/></p>
<p>在美国正在上演一则最令人悲伤的金融故事，沃尔格林联合博姿（WBA）正在崩溃，成为一只堕落的天使。该股票今年已经暴跌超过 68%，过去五年更是下跌了 80%。股价跌至 9.45 美元，处于 1997 年以来的最低点。</p>
<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2024/08/image-72.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2024/08/image-72.png"/></p>
<p><em>沃尔格林联合博姿股票</em></p>
<h2>为什么沃尔格林崩溃了</h2>
<p>沃尔格林的市值已经跌至 89.6 亿美元，远低于 2019 年的 500 亿美元。要了解公司跌至何种程度，可以考虑一下，2019 年股价达到顶峰时投资 1000 美元，如今仅值 150 美元，不包括股息。</p>
<p>该公司面临着诸多挑战。关键城市的零售盗窃一直是一个让人头疼的问题，已经给公司造成了数百万美元的损失。为了解决这个问题，公司被迫关闭了美国数百家门店并锁定产品。虽然锁定产品可以防止盗窃，但也会让顾客望而却步。</p>
<p>沃尔格林还因其过时的门店和在 2022 年失败的收购 VillageMD 而备受困扰，当时它试图打造一个完整的服务生态系统。这次收购结果很糟糕，公司大部分资产被减记，大部分员工被解雇。因此，公司报告了 60 亿美元的季度巨额亏损。</p>
<p>最重要的是，沃尔格林联合博姿正面临来自沃尔玛、Target 和亚马逊等公司的激烈竞争。其他数字药房也纷纷涌现。例如，Hims &amp; Hers（HIMS）的市值已经超过 34.8 亿美元，这对于一家 2017 年创立的公司来说是一个不错的成就。</p>
<p>沃尔格林还在努力剥离其 Boots 股份。其试图将其公开上市的努力失败，公司现在正在与潜在的私募股权公司进行讨论。</p>
<p>沃尔格林的困境让人想起了 RiteAid，这家公司在美国拥有第三大市场份额，但由于高债务负担而申请破产。</p>
<p>阅读更多：克莱默建议购买沃尔格林股票，尽管最近有员工大规模离职</p>
<h2>西维斯健康也不乐观</h2>
<p>从表面上看，西维斯健康和沃尔格林联合博姿是类似的公司，因为它们在美国都拥有数千家药店。</p>
<p>然而，这两家公司在很大程度上是不同的，因为西维斯经营着更多样化的业务模式。除了药店，西维斯健康还拥有 CVS Caremark，这是美国最大的药房福利管理公司（PBM）。Caremark 与 Express Scripts、OptumRx 和 Humana Pharmacy Solutions 等公司竞争。</p>
<p>西维斯健康还拥有 Aetna，这是它在 2018 年以 780 亿美元收购的公司。通过拥有 Aetna，公司能够为客户提供更多解决方案。此外，它在 2023 年以 100 亿美元收购了 Oak Street Health。这次收购使公司在初级保健业务中获得了更多机会。</p>
<p>然而，现实是西维斯健康也并不好，因为其药店业务也面临着与沃尔格林类似的挑战。</p>
<p>竞争加剧，而消费者现在更倾向于选择像亚马逊和沃尔玛这样提供免费运输服务的公司。这两项服务拥有数亿客户。它还花费数十亿美元改善其门店。</p>
<h2>西维斯的规模比收购 Aetna 的金额还小</h2>
<p>此外，经营成本上升，导致利润率降低。此外，公司同意支付 50 亿美元用于与阿片有关的指控。</p>
<p>因此，西维斯健康股价从 2022 年最高点暴跌超过 44%，目前处于 2020 年以来的最低点。因此，其市值已从 2020 年的超过 1,360 亿美元降至 730 亿美元。</p>
<p>换句话说，西维斯现在比收购 Aetna 的金额还要小。它的债务总额也增加，长期债务总额已上升至 610 亿美元以上。</p>
<p>最近的业绩显示，西维斯健康上季度收入增长了 2.6%，达到 912 亿美元，而半年自由现金流为 80 亿美元。</p>
<p>然而，公司还降低了其未来指引。它预计其自由现金流约为 90 亿美元，低于 105 亿美元，而其 GAAP 摊薄每股收益将在 4.95 美元至 5.20 美元之间，低于之前的 5.64 美元。</p>
<p>因此，有风险西维斯健康股价在短期内保持不稳定，因为交易员将关注其扭转局面。因此，虽然最终会反弹，但恢复可能需要时间。</p>
<h2>西维斯健康股票分析</h2>
<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2024/08/image-73.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2024/08/image-73.png"/></p>
<p><em>西维斯健康股票</em></p>
<p>周线图显示，西维斯股价在过去几周内保持稳定。在此过程中，它形成了一个看跌的旗形图表模式，这是一个流行的迹象，表明它将有一个看跌的突破。</p>
<p>股价一直低于 50 周和 100 周移动平均线。因此，股价可能会有一个看跌的突破，下一个关注点将是 45.58 美元，这是 2020 年 3 月的最低点，比当前水平低 21%。</p>
<p>文章来源：沃尔格林股价崩溃：西维斯健康如何？ - Invezz</p>

西维斯

沃尔格林联合博姿

<p>沃尔格林联合博姿（WBA）股票今年已经暴跌超过 68%，原因包括零售盗窃、过时门店和失败的收购，面临来自沃尔玛和亚马逊等大公司的激烈竞争。与此同时，西维斯（CVS Health）在进行更多多元化收购（如 Aetna）的同时，由于运营成本上升、与阿片类相关的指控以及竞争加剧，股价也下跌了超过 44%。两家公司都面临困境，而 CVS 现在的市值已经小于其对 Aetna 的收购成本</p>

<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2020/05/cvs-free-delivery-coronavirus-1584020000-740x416.jpg" alt="" original-src="https://invezz.com/wp-content/uploads/2020/05/cvs-free-delivery-coronavirus-1584020000-740x416.jpg"/></p>
<p>One of the saddest finance stories is unfolding in the United States, where Walgreens Boots Alliance (WBA) is imploding and becoming a fallen angel. The stock has crashed by over 68% this year and by 80% in the past five years. It has dropped to $9.45 and is hovering at its lowest point since 1997.</p>
<div class="lb-trans"><p>在美国正在上演一则最令人悲伤的金融故事，沃尔格林联合博姿（WBA）正在崩溃，成为一只堕落的天使。该股票今年已经暴跌超过 68%，过去五年更是下跌了 80%。股价跌至 9.45 美元，处于 1997 年以来的最低点。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2024/08/image-72.png" alt="" original-src="https://invezz.com/wp-content/uploads/2024/08/image-72.png"/></p>
<p><em>Walgreens Boots Allieance stock</em></p>
<div class="lb-trans"><p><em>沃尔格林联合博姿股票</em></p>
</div><h2>Why Walgreens has imploded</h2>
<div class="lb-trans"><h2>为什么沃尔格林崩溃了</h2>
</div><p>Walgreens’ market cap has dropped to $8.96 billion, down from over $50 billion in 2019. To understand how low the company has fallen, consider that $1,000 invested in the stock at its peak in 2019 would now be worth just $150, excluding dividends.</p>
<div class="lb-trans"><p>沃尔格林的市值已经跌至 89.6 亿美元，远低于 2019 年的 500 亿美元。要了解公司跌至何种程度，可以考虑一下，2019 年股价达到顶峰时投资 1000 美元，如今仅值 150 美元，不包括股息。</p>
</div><p>The company has faced numerous challenges. Retail theft in key cities has been a thorn in the flesh that has cost it millions of dollars. As a remedy, it has been forced to shut hundreds of stores in the US and lock products. While locking products prevents stealing, it also turns away customers.</p>
<div class="lb-trans"><p>该公司面临着诸多挑战。关键城市的零售盗窃一直是一个让人头疼的问题，已经给公司造成了数百万美元的损失。为了解决这个问题，公司被迫关闭了美国数百家门店并锁定产品。虽然锁定产品可以防止盗窃，但也会让顾客望而却步。</p>
</div><p>Walgreens is also suffering because of its outdated stores and its failed buyout of VillageMD in 2022 as it sought to create a full ecosystem of services. This purchase turned out to be a dud and the company wrote down most of it and fired most of the workers. As a result, it reported a big $6 billion quarterly loss.</p>
<div class="lb-trans"><p>沃尔格林还因其过时的门店和在 2022 年失败的收购 VillageMD 而备受困扰，当时它试图打造一个完整的服务生态系统。这次收购结果很糟糕，公司大部分资产被减记，大部分员工被解雇。因此，公司报告了 60 亿美元的季度巨额亏损。</p>
</div><p>Most importantly, Walgreens Boots Alliance is facing major competition from companies like Walmart, Target, and Amazon. Other digital pharmacies have also come up. For example, Hims &amp; Hers (HIMS) has attained a market cap of over $3.48 billion, a good achievement for a company that was started in 2017.</p>
<div class="lb-trans"><p>最重要的是，沃尔格林联合博姿正面临来自沃尔玛、Target 和亚马逊等公司的激烈竞争。其他数字药房也纷纷涌现。例如，Hims &amp; Hers（HIMS）的市值已经超过 34.8 亿美元，这对于一家 2017 年创立的公司来说是一个不错的成就。</p>
</div><p>Walgreens has also struggled to offload its Boots stake. Its attempts to take it public have failed and the company is now holding discussions with potential private equity companies.</p>
<div class="lb-trans"><p>沃尔格林还在努力剥离其 Boots 股份。其试图将其公开上市的努力失败，公司现在正在与潜在的私募股权公司进行讨论。</p>
</div><p>Walgreens’ woes have led to memories of RiteAid, a company that had the third-biggest market share in the US before it filed for bankruptcy because of its high debt burden.</p>
<div class="lb-trans"><p>沃尔格林的困境让人想起了 RiteAid，这家公司在美国拥有第三大市场份额，但由于高债务负担而申请破产。</p>
</div><p>Read more: Cramer recommends buying Walgreens stock despite recent walkout</p>
<div class="lb-trans"><p>阅读更多：克莱默建议购买沃尔格林股票，尽管最近有员工大规模离职</p>
</div><h2>CVS Health is not doing good either</h2>
<div class="lb-trans"><h2>西维斯健康也不乐观</h2>
</div><p>On paper, CVS Health and Walgreens Boots Alliance are similar companies since they both offer thousands of pharmacies in the United States.</p>
<div class="lb-trans"><p>从表面上看，西维斯健康和沃尔格林联合博姿是类似的公司，因为它们在美国都拥有数千家药店。</p>
</div><p>However, the two companies are significantly different since CVS operates a more diverse business model. In addition to its pharmacies, CVS Health owns CVS Caremark, the biggest pharmacy benefit manager (PBM) in the country. Caremark competes with the likes of Express Scripts, OptumRx, and Humana Pharmacy Solutions.</p>
<div class="lb-trans"><p>然而，这两家公司在很大程度上是不同的，因为西维斯经营着更多样化的业务模式。除了药店，西维斯健康还拥有 CVS Caremark，这是美国最大的药房福利管理公司（PBM）。Caremark 与 Express Scripts、OptumRx 和 Humana Pharmacy Solutions 等公司竞争。</p>
</div><p>CVS Health also owns Aetna, a company it acquired in 2018 in a $78 billion deal. By having Aetna, the company is able to offer more solutions to customers. Additionally, it acquired Oak Street Health in 2023 for $10 billion. The purchase gave the company more access in the primary care business.</p>
<div class="lb-trans"><p>西维斯健康还拥有 Aetna，这是它在 2018 年以 780 亿美元收购的公司。通过拥有 Aetna，公司能够为客户提供更多解决方案。此外，它在 2023 年以 100 亿美元收购了 Oak Street Health。这次收购使公司在初级保健业务中获得了更多机会。</p>
</div><p>However, the reality is that CVS Health is also not doing well since its pharmacy business is also facing similar challenges to Walgreens.</p>
<div class="lb-trans"><p>然而，现实是西维斯健康也并不好，因为其药店业务也面临着与沃尔格林类似的挑战。</p>
</div><p>Competition has risen while consumers are now opting for companies like Amazon and Walmart that have services like Prime and Walmart+ that offer free shipments. The two services have hundreds of millions of customers. It is also spending billions of dollars improving its stores.</p>
<div class="lb-trans"><p>竞争加剧，而消费者现在更倾向于选择像亚马逊和沃尔玛这样提供免费运输服务的公司。这两项服务拥有数亿客户。它还花费数十亿美元改善其门店。</p>
</div><h2>CVS is smaller than the amount it spent on Aetna</h2>
<div class="lb-trans"><h2>西维斯的规模比收购 Aetna 的金额还小</h2>
</div><p>Additionally, the cost of running its operations has risen, leading to lower margins. Also, it agreed to pay $5 billion for opioid related charges.</p>
<div class="lb-trans"><p>此外，经营成本上升，导致利润率降低。此外，公司同意支付 50 亿美元用于与阿片有关的指控。</p>
</div><p>As a result, CVS Health stock has plunged by over 44% from its highest point in 2022 and is hovering at the lowest point since 2020. As a result, its market cap has fallen from over $136 billion in 2020 to $73 billion.</p>
<div class="lb-trans"><p>因此，西维斯健康股价从 2022 年最高点暴跌超过 44%，目前处于 2020 年以来的最低点。因此，其市值已从 2020 年的超过 1,360 亿美元降至 730 亿美元。</p>
</div><p>In other words, CVS is now smaller than the amount it spent acquiring Aetna. It is also deeper in debt, with the total long-term debt rising to over $61 billion.</p>
<div class="lb-trans"><p>换句话说，西维斯现在比收购 Aetna 的金额还要小。它的债务总额也增加，长期债务总额已上升至 610 亿美元以上。</p>
</div><p>The most recent results showed that CVS Health’s revenue rose by 2.6% last quarter to $91.2 billion while its half-year free cash flow stood at $8 billion.</p>
<div class="lb-trans"><p>最近的业绩显示，西维斯健康上季度收入增长了 2.6%，达到 912 亿美元，而半年自由现金流为 80 亿美元。</p>
</div><p>However, the company also lowered its forward guidance. It expects that its FCF will be about $9 billion, down from $10.5 billion while its GAAP diluted EPS will be between $4.95 and $5.20 from the previous guidance of $5.64.</p>
<div class="lb-trans"><p>然而，公司还降低了其未来指引。它预计其自由现金流约为 90 亿美元，低于 105 亿美元，而其 GAAP 摊薄每股收益将在 4.95 美元至 5.20 美元之间，低于之前的 5.64 美元。</p>
</div><p>Therefore, there is a risk that the CVS Health stock price will remain on edge in the near term as traders focus on its turnaround. As such, while it will ultimately rebound, there is a possibility that the recovery will take time.</p>
<div class="lb-trans"><p>因此，有风险西维斯健康股价在短期内保持不稳定，因为交易员将关注其扭转局面。因此，虽然最终会反弹，但恢复可能需要时间。</p>
</div><h2>CVS Health stock analysis</h2>
<div class="lb-trans"><h2>西维斯健康股票分析</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2024/08/image-73.png" alt="" original-src="https://invezz.com/wp-content/uploads/2024/08/image-73.png"/></p>
<p><em>CVS Health stock</em></p>
<div class="lb-trans"><p><em>西维斯健康股票</em></p>
</div><p>The weekly chart shows that the CVS share price has consolidated in the past few weeks. In this, it has formed a bearish flag chart pattern, a popular sign that it will have a bearish breakout.</p>
<div class="lb-trans"><p>周线图显示，西维斯股价在过去几周内保持稳定。在此过程中，它形成了一个看跌的旗形图表模式，这是一个流行的迹象，表明它将有一个看跌的突破。</p>
</div><p>The stock has remained below the 50-week and 100-week moving averages. Therefore, the stock will likely have a bearish breakout, with the next point to watch being at $45.58, its lowest swing in March 2020 and 21% below the current level.</p>
<div class="lb-trans"><p>股价一直低于 50 周和 100 周移动平均线。因此，股价可能会有一个看跌的突破，下一个关注点将是 45.58 美元，这是 2020 年 3 月的最低点，比当前水平低 21%。</p>
</div><p>The post Walgreens stock has fallen apart: is CVS Health any better? appeared first on Invezz</p>
<div class="lb-trans"><p>文章来源：沃尔格林股价崩溃：西维斯健康如何？ - Invezz</p>
</div>

沃尔格林联合博姿的股票崩盘了：西维斯的表现会更好吗？